Altabas V
Department for Endocrinology, Diabetes and Metabolic Diseases "Mladen Sekso", Clinic for Internal Medicine, University Hospital Center "Sestre Milosrdnice", 10000 Zagreb, Croatia.
Int J Endocrinol. 2015;2015:848272. doi: 10.1155/2015/848272. Epub 2015 May 18.
Cardiovascular complications are the most common complications of diabetes mellitus. A prominent attribute of diabetic cardiovascular complications is accelerated atherosclerosis, considered as a still incurable disease, at least at more advanced stages. The discovery of endothelial progenitor cells (EPCs), able to replace old and injured mature endothelial cells and capable of differentiating into healthy and functional endothelial cells, has offered the prospect of merging the traditional theories on the pathogenesis of atherosclerosis with evolving concepts of vascular biology. The literature supports the notion that EPC alterations are involved in the pathogenesis of vascular diseases in diabetics, but at present many questions remain unanswered. In this review the aspects linking endothelial progenitor cells to the altered vascular biology in diabetes mellitus are discussed.
心血管并发症是糖尿病最常见的并发症。糖尿病心血管并发症的一个突出特征是动脉粥样硬化加速,这被认为是一种至少在更晚期阶段仍无法治愈的疾病。内皮祖细胞(EPCs)的发现,能够替代衰老和受损的成熟内皮细胞,并能够分化为健康且功能正常的内皮细胞,为将动脉粥样硬化发病机制的传统理论与不断发展的血管生物学概念相结合提供了前景。文献支持内皮祖细胞改变参与糖尿病患者血管疾病发病机制的观点,但目前许多问题仍未得到解答。在这篇综述中,我们将讨论内皮祖细胞与糖尿病血管生物学改变之间的联系。